ANTI-IDIOTYPIC B-CELL LINES FROM A PATIENT WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE

被引:7
作者
ANDERSSON, M
HOLM, G
LEFVERT, AK
MELLSTEDT, H
机构
[1] KAROLINSKA HOSP,DEPT MED,DIV IMMUNOL & HAEMATOL,S-10401 STOCKHOLM 60,SWEDEN
[2] KAROLINSKA HOSP,RADIUM HEMMET,DEPT ONCOL,S-10401 STOCKHOLM,SWEDEN
关键词
D O I
10.1111/j.1365-3083.1989.tb02454.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:489 / 492
页数:4
相关论文
共 14 条
[1]   NETWORK THEORY IN AUTOIMMUNITY - INVITRO SUPPRESSION OF SERUM ANTI-DNA ANTIBODY-BINDING TO DNA BY ANTI-IDIOTYPIC ANTIBODY IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ABDOU, NI ;
WALL, H ;
LINDSLEY, HB ;
HALSEY, JF ;
SUZUKI, T .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (05) :1297-1304
[2]  
BONA CA, 1988, BIOL APPLICATIONS AN, V2
[3]   HUMAN MONOCLONAL IMMUNOGLOBULINS THAT BIND THE HUMAN ACETYLCHOLINE-RECEPTOR [J].
ENG, H ;
LEFVERT, AK ;
MELLSTEDT, H ;
OSTERBORG, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (12) :1867-1869
[4]   TUMOR IMMUNITY INDUCED BY PRE-IMMUNIZATION WITH BALB-C MOUSE MYELOMA PROTEIN [J].
FREEDMAN, PM ;
AUTRY, JR ;
TOKUDA, S ;
WILLIAMS, RC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1976, 56 (04) :735-740
[5]  
JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373
[6]   BINDING-PROPERTIES AND SUBCLASS DISTRIBUTION OF ANTI-ACETYLCHOLINE RECEPTOR ANTIBODIES IN MYASTHENIA-GRAVIS [J].
LEFVERT, AK ;
CUENOUD, S ;
FULPIUS, BW .
JOURNAL OF NEUROIMMUNOLOGY, 1981, 1 (01) :125-135
[7]   IDIOTYPIC NETWORK IN MYASTHENIA-GRAVIS DEMONSTRATED BY HUMAN MONOCLONAL B-CELL LINES [J].
LEFVERT, AK ;
HOLM, G .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1987, 26 (05) :573-578
[8]  
LEFVERT AK, 1988, BIOL APPLICATIONS C, V2, P69
[9]   THE USE OF MYELOMA CELLS TO STUDY IMMUNOREGULATORY MECHANISMS [J].
LYNCH, RG ;
MILBURN, GL .
IMMUNOLOGY TODAY, 1983, 4 (11) :326-330
[10]   IMMUNOREGULATION OF MURINE MYELOMA INVITRO .2. SUPPRESSION OF MOPC-315 IMMUNOGLOBULIN SECRETION AND SYNTHESIS BY IDIOTYPE-SPECIFIC SUPPRESSOR T-CELLS [J].
MILBURN, GL ;
LYNCH, RG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (03) :852-862